Search - tctmd.com

Displaying 261 - 280 of 1569

Sort: Relevancy | Date

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

News Conference News TCT 2021

LAA Closure Feasible in Patients With Thrombus: Registry

Michael O'Riordan

October 13, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

Presentation TCT 2020

I Recommend Renal Denervation!

Presenter: Andrew Sharp

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presenter: Manuela Negoita

October 15, 2020

Presentation TCT 2020

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

Presenter: Salvatore Brugaletta

October 15, 2020

Advertisement

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Good Long-term Results With FANTOM BVS, but More Data Needed

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

No Harm From Thrombolytics in SCAD Patients With STEMI

LAA Closure Feasible in Patients With Thrombus: Registry

Failed MitraClip Is Uncommon, but Bleak When It Happens

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Treating Accessory Arteries May Be Important in Renal Denervation

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

I Recommend Renal Denervation!

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Industry Sponsors (Supporting Innovation and Medical Device Approval)

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content